Comparative Effectiveness research has been identified as a top
priority of the Administration and health care reform. President Obama’s stimulus package allotted
$1.1Billion to the furtherance of comparative effectiveness research and the
Committees are now being formed to address the priorities and the focus those
studies should take. That sum is being
dispensed as $300 million for Agency for Healthcare Research and Quality
(AHRQ), $400 million for National Institutes of Health (NIH) and $400M for the
Secretary of Health and Human Services (CMS).
The Council will not recommend clinical guidelines for payment,
coverage or treatment, but will address priorities and investments for the
forthcoming research allocations. The
group is called the Federal Coordinating Council for Comparative Effectiveness
Research and it is made up of 15 members from diverse agencies or individuals,
mostly clinicians. The individuals and
agencies they represent are noted below:
HHS:
Anne Haddix,
PhD, CDC
Thomas Valuck, MD,
MHSA, JD, CMS
Peter Delany, PhD,
LCSW-C, SAMHSA
Carolyn Clancy,
MD, AHRQ
Deborah Parham
Hopson, PhD, RN, FAAN, HRSA
David Hunt, MD,
ONC
James Scanlon,
Planning and Evaluation
Elizabeth Nabel,
MD, NIH
Garth Graham, MD,
MPH, Office of Minority Health
James Goodman, MD,
MPH, Center for Biologics Evaluation and Research, FDA
Michael Marge,
Office on Disability
Neera Tanden,
Office of the Secretary
OTHER DEPARTMENTS
Joel Kupersmith,
MD, VA
Michael Kilpatrick,
MD, DOD
Ezekiel Emanuel,
MD PhD, OMB
In furtherance of openness and transparency the Coordinating Council
will host open meetings and listening sessions, the first of which is scheduled
for April 14, 2009.
|
